Loading...
RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106
Aggressive induction chemotherapy followed by autologous haematopoietic stem cell transplant (auto-HCT) is effective for younger patients with mantle cell lymphoma (MCL). However, the optimal induction regimen is widely debated. The Southwesterm Oncology Group S1106 trial was designed to assess ritu...
Na minha lista:
| Udgivet i: | Br J Haematol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5318240/ https://ncbi.nlm.nih.gov/pubmed/27992063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.14480 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|